Why the study?
Few studies have investigated the role of the neutrophil to high-density lipoprotein cholesterol ratio in assessing the risk of ACS in patients with T2DM.
Does the neutrophil to high-density lipoprotein cholesterol ratio (NHR) predict the presence of acute coronary syndrome in patients with type 2 diabetes mellitus?
Does the neutrophil to high-density lipoprotein cholesterol ratio (NHR) predict the presence of acute coronary syndrome in patients with type 2 diabetes mellitus?
The neutrophil to high-density lipoprotein cholesterol ratio (NHR) is a readily available biomarker that independently correlates with myocardial injury and predicts the presence of acute coronary syndrome in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
NHR may aid ACS risk stratification in T2DM without changing practice; leaves open incremental value and need for prospective validation.
Ren et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: